- Home
- FSP vs IMA Comparison
FSP vs IMA Comparison
Compare FSP & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSP | IMA |
|---|---|---|
| Founded | 1981 | 2019 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 65.3M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | FSP | IMA |
|---|---|---|
| Price | $0.59 | $5.70 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 619.0K | 30.9K |
| Earning Date | 03-09-2026 | 03-10-2026 |
| Dividend Yield | ★ 6.84% | N/A |
| EPS Growth | ★ 15.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $107,162,000.00 | N/A |
| Revenue This Year | $17.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $5.35 |
| 52 Week High | $1.93 | $17.50 |
Technical Indicators
Market Signals| Indicator | FSP | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 33.56 | 38.78 |
| Support Level | N/A | N/A |
| Resistance Level | $0.86 | $7.28 |
| Average True Range (ATR) | 0.05 | 0.41 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 16.00 | 38.17 |
Price Performance
Historical ComparisonAbout FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.